News | Media Coverage
- July 8, 2008
Palo Alto/KGO ABC7 News
APT supports Team Northern California at USA Transplant Games 
- May 8, 2008
Start-Up Magazine
APT profiled in Start-Up Magazine 
- November 2, 2007
Silicon Valley/San Jose Business Journal
APT Moves Are Closely Followed 
- October 5, 2007
Dow Jones VentureWire
Specialty Drug Co. APT Pharma Breathes In $22M 
- October 5, 2007
BioWorld Today
APT Targeting Lung Transplant, Disease With $22M Financing 
- June 15, 2007
San Francisco Business Times
Chiron Refugees Adopt 'Orphans' from Novartis
News | Press Releases
- February 24, 2010
- APT Pharmaceuticals Completes Enrollment in Phase III for Inhaled Cyclosporine
- January 15, 2009
- APT Pharmaceuticals Adds Stephen Aselage to Board of Directors
- September 30, 2008
- APT Pharmaceuticals Secures $32 Million in Series B Financing
- December 3, 2007
- APT Pharmaceuticals Adds Paul Sekhri to Board of Directors
- November 19, 2007
- APT Pharmaceuticals Expands Management Team
- October 4, 2007
- APT Pharmaceuticals Closes New $22 Million Funding Round
- June 5, 2007
- APT Acquires Exclusive Worldwide Rights to Develop and Commercialize Inhalable Cyclosporine to Prevent Lung Transplant Rejection
- September 6, 2006
- Former Chiron Executive Joins APT Pharmaceuticals as CEO
- March 21, 2006
- APT Pharmaceuticals Adds Vivo Ventures in Final Close of $9 Million First Round